Cerivastatin, genetic variants, and the risk of rhabdomyolysis.
Marciante KD, Durda JP, Heckbert SR, Lumley T, Rice K, McKnight B, Totah RA, Tamraz B, Kroetz DL, Fukushima H, Kaspera R, Bis JC, Glazer NL, Li G, Austin TR, Taylor KD, Rotter JI, Jaquish CE, Kwok PY, Tracy RP, Psaty BM.
Marciante KD, et al. Among authors: fukushima h.
Pharmacogenet Genomics. 2011 May;21(5):280-8. doi: 10.1097/FPC.0b013e328343dd7d.
Pharmacogenet Genomics. 2011.
PMID: 21386754
Free PMC article.